Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Renewal Bio is a next-generation biotechnology company focused on addressing global shortages of transplantable cells and organs through advanced synthetic embryology. Founded by world-renowned stem cell scientist Professor Jacob Hanna, the company utilizes its proprietary Stembroid™ platform to generate authentic, DNA-identical human cells and tissues from naïve pluripotent stem cells. By mimicking natural embryonic development, Renewal Bio aims to produce scalable, immune-compatible alternatives to donor transplants for indications such as leukemia, infertility, and organ failure. The company's near-term focus includes the development of hematopoietic stem cells (HSCs) to revolutionize bone marrow transplants and immune disorder treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Renewal Center.